Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).
Island Pharmaceuticals Ltd has been accepted into the Medical Countermeasures Coalition (MC2), a significant step in advancing its antiviral drug, Galidesivir, as a priority countermeasure. This membership is expected to bolster the company’s regulatory, clinical, and stockpiling efforts, enhancing its engagement with the US Government and positioning it alongside major biotechnology firms in the coalition.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd is an Australian company specializing in the development of antiviral drugs. The company focuses on creating critical countermeasures against high-priority threats, aiming for inclusion in government stockpiles.
Average Trading Volume: 752,237
Technical Sentiment Signal: Buy
Current Market Cap: A$132.4M
Find detailed analytics on ILA stock on TipRanks’ Stock Analysis page.